Skip to content

GCRI · Biotechnology and Biosecurity

Diagnostics and therapeutics

Diagnostics detect disease; therapeutics and vaccines prevent or treat it. Biotechnology has transformed both, from molecular tests to biologic medicines and platform vaccines. This topic, studied at Biotechnology and Biosecurity, a platform of The Global Centre for Risk and Innovation (GCRI), examines how health innovations are evaluated, how evidence of performance is generated and judged, and how access and supply shape their value in practice. It is research, not clinical guidance.

01Core questions

What experts ask.

  • How is the accuracy of a diagnostic test established, and how does it vary by setting?
  • How do clinical trials balance speed and reliability, especially in emergencies?
  • How do platform technologies change the time needed to develop countermeasures?
  • What determines whether innovations reach the people who need them?
  • How is safety monitored once products are in wide use?
02Geography

Environmental exposure in West Africa.

Daytime surface heat, population density and haze over West Africa, from NASA GIBS. Each layer carries its own date.

Die interaktiewe kaart benodig JavaScript; die laaglys en bronne is hieronder.

Lae 3

Environmental exposure, for this page

Oor hierdie laag
Bewyse
Waargeneem (aanhoudende wolke laat steeds gapings)
Bron
VIIRS NOAA-20 Vlak 3, 8-dag (NASA LANCE)
Verskaffer
NASA LANCE
Lisensie
NASA-oopdata
Oesjaar
8-dag; Satelliet-8-dag-samestelling; aanhoudende wolke laat steeds gapings
Nuutste by bou
2026-09-14
Resolusie
ongeveer 1 km-rooster
Onsekerheid
Satelliet-oppervlaktemperatuur van die grond oor die 8 dae wat op die getoonde datum eindig, ’n aanwyser van hitteblootstelling; nie lugtemperatuur, hitte-indeks of ’n hittewaarskuwing nie.
Bereik deur
hierdie werf se data-aanstuurder, vanaf gibs.earthdata.nasa.gov
Oor hierdie laag
Bewyse
Geskat
Bron
Gridded Population of the World v4.11 (NASA SEDAC (CIESIN, Columbia-universiteit))
Verskaffer
NASA SEDAC (CIESIN, Columbia-universiteit)
Lisensie
CC BY 4.0
Oesjaar
null; Sensusgebaseerde skatting, staties (2020)
Resolusie
ongeveer 1 km-rooster
Onsekerheid
Sensusgebaseerde skatting van mense per vierkante kilometer in 2020, getoon as blootstellingskonteks; nie ’n telling van mense wat deur enige gevaar geraak word nie.
Bereik deur
hierdie werf se data-aanstuurder, vanaf gibs.earthdata.nasa.gov
Oor hierdie laag
Bewyse
Waargeneem (wolke laat gapings)
Bron
VIIRS NOAA-20 Deep Blue AOD (NASA LANCE)
Verskaffer
NASA LANCE
Lisensie
NASA-oopdata
Oesjaar
daagliks; Satellietherwinning; wolke laat gapings
Nuutste by bou
2026-10-14
Resolusie
ongeveer 2 km-rooster
Onsekerheid
Satellietmeting van waas, rook en stof deur die hele lugkolom op die getoonde dag; ’n blootstellingsaanwyser, nie PM2.5 op grondvlak, ’n luggehalte-indeks of ’n gesondheidswaarskuwing nie.
Bereik deur
hierdie werf se data-aanstuurder, vanaf gibs.earthdata.nasa.gov
Oor hierdie laag
Bewyse
Waargeneem (wolke laat gapings)
Bron
MODIS Terra NDVI (NASA LANCE)
Verskaffer
NASA LANCE
Lisensie
NASA-oopdata
Oesjaar
daily; Satellite index; clouds leave gaps
Nuutste by bou
2026-10-13
Resolusie
ongeveer 250 m-rooster
Onsekerheid
Satellite greenness index over the 8 days to the date shown; an indicator of crop and pasture condition, not a yield estimate or a food security warning.
Bereik deur
hierdie werf se data-aanstuurder, vanaf gibs.earthdata.nasa.gov
Oor hierdie laag
Bewyse
Waargeneem (wolke laat gapings)
Bron
OMI Aura (NASA GES DISC)
Verskaffer
NASA GES DISC
Lisensie
NASA-oopdata
Oesjaar
daagliks; Satellietherwinning; wolke laat gapings
Nuutste by bou
2026-10-10
Resolusie
ongeveer 2 km-rooster
Onsekerheid
Satellite column of nitrogen dioxide in the lower atmosphere on the day shown, mostly from combustion; not a ground-level concentration or a health warning.
Bereik deur
hierdie werf se data-aanstuurder, vanaf gibs.earthdata.nasa.gov
Oor hierdie laag
Bewyse
Waargeneem
Bron
VIIRS NOAA-20 corrected reflectance (NASA LANCE)
Verskaffer
NASA LANCE
Lisensie
NASA-oopdata
Oesjaar
daily; Satellite image
Nuutste by bou
2026-10-14
Resolusie
ongeveer 250 m-rooster
Onsekerheid
Satellite image. Satellite or model raster as the provider publishes it. Clouds, swath gaps and retrieval error leave gaps and noise; values are indicators, not measurements at a place.
Bereik deur
hierdie werf se data-aanstuurder, vanaf gibs.earthdata.nasa.gov

Nuutste beskikbaar

NASA GIBS / EOSDIS · ASTER GDEM (METI, NASA) · Blue Marble (NASA) · © OpenStreetMap-bydraers (ODbL) · Natural Earth

Laai tans die nuutste NASA-beelde.

Sleep om te skuif. Ctrl of ⌘ en rol, knyp of die knoppies om te zoem; sweef vir die waardes onder die wyser; terugstel keer terug na die streek.

Environmental exposure, framed on West Africa.Satellite and model products as NASA publishes them, each with its own date. They are indicators, not assessments of any place.

Data: NASA GIBS · ASTER GDEM · Blue Marble · © OpenStreetMap contributors · Natural Earth · NASA EONET · ESA Copernicus Sentinel-5P TROPOMI · NASA JPL OPERA DIST-ALERTSources and licences

  • We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS). Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS). Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • VIIRS near-real-time products (flood, land surface temperature, snow cover, corrected reflectance), NASA LANCE; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • Center for International Earth Science Information Network (CIESIN), Columbia University. 2018. Gridded Population of the World, Version 4 (GPWv4): Population Density, Revision 11. NASA Socioeconomic Data and Applications Center (SEDAC). Licensed under CC BY 4.0. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). doi:10.7927/H49C6VHW. CC BY 4.0
  • MODIS and VIIRS atmosphere products, NASA LANCE and LAADS DAAC; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • MODIS land products (vegetation indices, gross primary production, land cover), NASA LP DAAC and LANCE; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • OMI nitrogen dioxide (Aura) and OMPS aerosol index (Suomi NPP), NASA; distributed by the NASA GES DISC; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • ASTER GDEM is a product of METI and NASA (ASTER Global Digital Elevation Model V003, NASA LP DAAC); imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). Cite as: NASA/METI/AIST/Japan Spacesystems and U.S./Japan ASTER Science Team (2019). ASTER Global Digital Elevation Model V003. doi:10.5067/ASTER/ASTGTM.003. NASA open data
  • Gemaak met Natural Earth. Gratis vektor- en rasterkaartdata @ naturalearthdata.com. Openbare domein
  • © OpenStreetMap contributors (ODbL), via NASA GIBS (coastlines, boundaries, roads and place names). Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). ODbL
  • Blue Marble, NASA Earth Observatory; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • Konteks op die aardbol en platkaart: kuslyne, grense, paaie en plekname uit NASA GIBS-verwysingslae (OpenStreetMap-data, ODbL, © OpenStreetMap contributors); Blue Marble-beelde as 'n opsionele basis; 3D-terrein en die hoogte-aflesing vanaf die ASTER GDEM-hoogtekleurindeks (klasse van 5 m tot 200 m, vir leesbaarheid oordryf). Grense word geteken soos gepubliseer en impliseer geen standpunt oor enige gebied nie.
  • Lewende gebeure: NASA Earth Observatory Natural Event Tracker (EONET); gebeure is aanduidend en behou hul oorspronklike bronskakels.
  • Observed (EO): ESA Copernicus Sentinel-5P TROPOMI (contains modified Copernicus Sentinel data 2026). We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS).
  • Observed (EO): NASA JPL OPERA DIST-ALERT (contains modified Copernicus Sentinel data 2026). We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS).
  • NASA GIBS: Ons erken die gebruik van beelde verskaf deur dienste van NASA se Global Imagery Browse Services (GIBS), deel van NASA se Earth Science Data and Information System (ESDIS).
  • Air quality forecast, 5 days, PM2.5 (CAMS via Open-Meteo): Contains modified Copernicus Atmosphere Monitoring Service information 2026.
  • Past year, daily temperature (ERA5 via Open-Meteo): Contains modified Copernicus Climate Change Service information 2026.
  • Weerdata deur Open-Meteo.com (https://open-meteo.com/), gelisensieer onder CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
  • Optional layers (14 sources in the layer list: live, forecast, observed and context) print their provider credit on the map and here when switched on; forecasts are model output and derived indices are estimates.

Lae en datums

  • Landoppervlaktemperatuur, dag, 8-dae-saamgestelde beeld: VIIRS NOAA-20 Level 3, 8-dae, NASA LANCE · 14 Sep. 2026
  • Population density, 2020: Population: CIESIN, Columbia University, Gridded Population of the World v4.11 (2018), NASA SEDAC, CC BY 4.0 · static
  • Aërosol-optiese diepte, daagliks: VIIRS NOAA-20 Deep Blue AOD, NASA LANCE · 13 Oktober 2026
  • Vegetation greenness (NDVI), rolling 8 days: MODIS Terra NDVI, NASA LANCE · 13 Oct 2026
  • Nitrogen dioxide, lower atmosphere column: OMI Aura, NASA GES DISC · 10 Oct 2026
  • Ware kleur: VIIRS NOAA-20 gekorrigeerde weerkaatsing, NASA LANCE · 13 Oktober 2026

03Across the domains

Countermeasures protect health and depend on other domains.

Countermeasure studies are designed for the Strategic Systems series. The WHO R&D Blueprint and the Essential Medicines List (24th list, 2025) frame priorities; GCRI approves no product.

  • Access and supply studies.
  • Evaluations of diagnostic deployment.
04Monitor

Oversight and capacity register.

The screen a team would use to follow this subject: its measures, states and decisions. Names are examples and values are illustrative.

Oversight and capacity register

Diagnostics and therapeutics · National committee · Review year 3

  • Institutions with a committee, %
    83Watch
  • Staff trained, %
    87Normal
  • Reviews completed
    40this year
  • Incident reports filed
    5Info
Capacity and oversight onlyGCRI · Biotechnology and Biosecurity

Institutional oversight

Institution AActiveQ284Current
Research campusActiveQ161Audit due
Biomanufacturing siteFormingnone67Ondersteuning
Diagnostic networkActiveQ388Current

Scope note

Covers
governance, training, review capacity
Excludes
technical methods and agents
Authority
national oversight body
Label
SURVEY
Oversight and capacity register: the screen’s structure, terms and states for Diagnostics and therapeutics.Example names and illustrative values; a design, not a record or a live system.
05Mechanisms

Drivers and dynamics.

A diagnostic test’s usefulness depends on its sensitivity and specificity and on how common the condition is in the population tested, so the same test can perform differently in different settings. Therapeutics and vaccines are evaluated through staged trials, with regulators weighing evidence of benefit against risk. Emergency procedures can accelerate this process, at the cost of more uncertainty at the time of decision.

Platform technologies, which can be adapted to new targets, have shortened development times for some countermeasures. Yet value in practice depends on manufacturing, distribution, affordability and trust. Surveillance after approval detects rare adverse effects that trials are too small to find. Population health questions are studied at Health Nexus.

06Twin and cascade simulator

Model diagnostics and therapeutics as a system. Run the cascade.

Assembled from the Nexus Standards area profile Biological hazard standards: the hazards it names, the systems and sectors that carry the loss, the controls that dampen it and the data that observe it. Choose the components, pick an initiating hazard and step through the cascade. The Map view places the run on an example geography with open data. Every coupling weight is a stated assumption you can change. A teaching model, not a forecast, an assessment or a certification. To model a place of your own choosing, open the full System Builder.

Controls

  • NS-0 Grondwet en beginsels
  • NS-3 Risikorekord-UNI's (grammatika, oorerflike kruisverwysing, toewysingsgesag)
  • NS-11 Verifikasie en monitering (getuienis, attestasies, zero-trust-ooreenstemmingwaarneming)
  • NRS-H41 Hazard family: Animal-to-human spillover (NHS-1 health.zoonotic)
  • NRS-H44 Hazard family: Plant disease and pests (NHS-1 health.plant-health)
  • NRS-H43 Hazard family: Livestock and aquaculture epizootics (NHS-1 health.animal-health)
  • NRS-H35 Hazard family: Airborne and respiratory infection (NHS-1 health.respiratory)
  • NRS-H40 Hazard family: Blood-borne and sexually transmitted infection (NHS-1 health.bloodborne)
  • NRS-H60 Hazard family: Supply-chain and flow disruption (NHS-1 sys.supply-chain)

Observation

  • WHO Disease Outbreak News (listed for reference)
  • WAHIS animal health events (listed for reference)
  • GBIF occurrence API and downloads (listed for reference)
  • International Health Regulations capacity and health emergency preparedness
  • Proportion of countries adopting relevant national legislation and adequately resourcing the prevention or control of invasive alien species

Example geography

  • West Africa: 59 hexagonal cells
  • Night lights tonight, outages (VIIRS Day/Night Band), NASA GIBS
07Methods and limits

How it is studied.

  1. 01

    Evidence synthesis

    Systematic reviews and meta-analyses pool results across studies, with attention to bias.

  2. 02

    Statistical evaluation

    Methods from probability and statistics assess test accuracy, trial design and uncertainty.

  3. 03

    Health technology assessment

    Frameworks compare benefits, risks and costs, drawing on epidemiology and public health science.

  4. 04

    Limits

    Trials may not represent all populations, published evidence can be biased toward positive results, and performance in practice often differs from performance in trials.

08Methods and evidence

How diagnostics and therapeutics is modelled, measured and tested.

The model, its assumptions, its data and its uncertainty, in the form a scientist or engineer would check. Structures follow published methods. The values drawn are illustrative, not findings.

System model

The couplings between the systems in diagnostics and therapeutics: signs of influence, a reinforcing and a balancing loop, and cross-links where stress jumps.

++−+GesondheidVoedselGemeenskappeEkonomieR reinforcingB balancing
Causal loop diagram from the page’s systems; signs show the direction of influence. Illustrative structure for a system dynamics or network model, not estimated couplings.
FAIR guiding principles · GO FAIR and FORCE11W3C PROV · World Wide Web ConsortiumGuidance on consistent treatment of uncertainties · IPCCCEOS Analysis Ready Data · Committee on Earth Observation Satellites
09Decisions

What it informs and who decides.

This evidence informs regulatory decisions, procurement and stockpiling, health technology assessment and preparedness planning. Regulators, health agencies and clinicians decide; GCRI is not a health-service provider or clinical authority. The insurance-sector reading of health innovation and pandemic risk is built by Insurance Nexus at The Global Risks Alliance (GRA). Related topics are biomanufacturing, biological threats and One Health impacts; methods sit on epidemiology and public health science and probability and statistics.

Published analysis on this topic is designed to carry a named subject reviewer, its references and the views of independent specialists, including biosafety professionals and those who disagree.

10Bronne

Where this page’s references lead.

The bodies and documents this page is read against. Status and editions change; each link goes to the issuing body.

11Vrae

Questions and answers.

Can the platform tell me which test or treatment to use?
No. It does not provide clinical advice. Health professionals and regulators make those decisions.
Why can an accurate test give misleading results?
Because a test’s predictive value depends on how common the condition is in the people tested, not only on its accuracy.
Are emergency approvals less reliable?
They are made with less evidence at the time of decision, so monitoring after approval matters more.
Who reviews coverage of this topic?
Published analysis is designed to be reviewed by a named subject reviewer with relevant expertise, to cite its references and to include independent specialist voices. Where specialists disagree, the disagreement is reported rather than resolved by omission.
VerslaeDra by

Dra bewyse vanaf hierdie bladsy by.

Reports is the Consortium’s quarterly publication. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work.

GCRIBiotechnology and BiosecurityExponential TechnologyEvidence Brief
Biotegnologie en biosekuriteit

Bring a method, a dataset or a question.

Information and enquiries are open today. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.